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Abstract
Osteogenesis Imperfecta (OI) is a human syndrome characterized by exquisitely fragile bones due to osteoporosis. The
majority of autosomal dominant OI cases result from point or splice site mutations in the type I collagen genes, which are
thought to lead to aberrant osteoid within developing bones. OI also occurs in humans with homozygous mutations in
Prolyl-3-Hydroxylase-1 (LEPRE1). Although P3H1 is known to hydroxylate a single residue (pro-986) in type I collagen chains,
it is unclear how this modification acts to facilitate collagen fibril formation. P3H1 exists in a complex with CRTAP and the
peptidyl-prolyl isomerase cyclophilin B (CypB), encoded by the Ppib gene. Mutations in CRTAP cause OI in mice and humans,
through an unknown mechanism, while the role of CypB in this complex has been a complete mystery. To study the role of
mammalian CypB, we generated mice lacking this protein. Early in life, Ppib-/- mice developed kyphosis and severe
osteoporosis. Collagen fibrils in Ppib-/- mice had abnormal morphology, further consistent with an OI phenotype. In vitro
studies revealed that in CypB–deficient fibroblasts, procollagen did not localize properly to the golgi. We found that levels
of P3H1 were substantially reduced in Ppib-/- cells, while CRTAP was unaffected by loss of CypB. Conversely, knockdown of
either P3H1 or CRTAP did not affect cellular levels of CypB, but prevented its interaction with collagen in vitro. Furthermore,
knockdown of CRTAP also caused depletion of cellular P3H1. Consistent with these changes, post translational prolyl-3-
hydroxylation of type I collagen by P3H1 was essentially absent in CypB–deficient cells and tissues from CypB–knockout
mice. These data provide significant new mechanistic insight into the pathophysiology of OI and reveal how the members
of the P3H1/CRTAP/CypB complex interact to direct proper formation of collagen and bone.
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Introduction
OI is an inherited disorder of collagen, affecting one in 12,000
newborns [1,2]. Point mutations in the type I collagen genes
COL1A1 or COL1A2 are responsible for the majority of cases,
which are typically autosomal dominant. The severity of symptoms
of OI is highly heterogeneous, ranging from mild increased risk of
bone fractures to neonatal lethality. Recently, mutations in the
endoplasmic reticulum (ER)-resident proteins Prolyl-3-hydroxylase-
1 (P3H1, also known as LEPRE1) or its binding partner CRTAP
werefoundtobecausativeinasubsetofautosomalrecessiveformsof
OI in humans and/or mice [3–5]. P3H1 hydroxylates a single
residue (proline-986) of procollagen shortly after secretion into the
ER,andthismodificationispostulatedtofacilitatetheproperfolding
or stability of collagen trimers [6]. Although CRTAP mutants also
show deficient prolyl-3-hydroxylation of collagen, how this protein
supports the function of P3H1 has not been elucidated. Cyclophilin
B hasbeenfoundin association withP3H1and CRTAP,howeverits
function in the complex is completely unknown [5,7,8].
Cyclophilins form a class of proteins originally discovered by
virtue of their high specific affinity for the immunosuppressant drug
cyclosporin A [9]. They are thought to accelerate the folding of
proteins by catalyzing the isomerization of peptidyl-proline bonds,
which are normally constrained in their rotation [10]. Cyclophilins
are highly conserved throughout evolution, and the different
isoforms display substantial sequence similarity in their central
cyclosporine-binding domains. Individual differences at N- and C-
termini of the various family members direct their subcellular
localizations and protein-protein interactions. The initial cyclophi-
lin discovered, cyclophilin A, is primarily cytosolic, and was shown
to mediate the immunosuppressive effect of cyclosporin by creating
an inhibitory complex with calcineurin [11,12]. Cyclophilin A plays
an essential role in blocking the activity of the lymphocyte tyrosine
kinaseItk,and micelackingthe Ppiagene developallergicsymptoms
due to enhanced Itk-induced TH2 cells [13].
Cyclophilin B (CypB) is a highly related family member that is
present within the endoplasmic reticulum (ER) of all cell types
[14]. In vitro studies have previously suggested a possible role for
CypB in multiple diverse functions, including immunosuppression
[15], chemotaxis [16], hepatitis C virus replication [17], and
prolactin signaling [18]. As an ER-resident, it was also postulated
to be involved in post-translational folding of secreted proteins,
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established to date. CypB has also been found to associate with
collagen [19].
An important feature of patients with OI is the high degree of
variability in the severity of their disease symptoms. The causes for
this variability are not understood, however it is likely that there
are unlinked modifier genes that impact the phenotypic spectrum
of disease severity [2,20]. In addition, some patients with OI do
not have mutations in any known disease-related genes. Thus, it is
important to identify additional genes that direct the proper
biosynthesis and assembly of procollagen into fibrils. In this report,
we identify CypB as a new OI phenotype disease-gene in mice,
and explore the function of its interactions with P3H1 and
CRTAP.
Results
Reduced body size and kyphosis in CypB knockout mice
To determine the role of CypB in vivo, we targeted exon 3 by
homologous recombination, and generated mice bearing the
knockout allele (Figure 1A). The resulting allele contains an out of
frame join between exons 2 and 4, thus was predicted to
completely inactivate the gene. Mating of heterozygote mutant
mice gave rise to viable homozygous knockouts at the expected
Mendelian ratio. Successful deletion of the gene was verified by
Southern blotting (Figure 1B) and by Western blotting (Figure 1C,
Figure S1A). mRNA generated from the mutated allele accumu-
lated to significantly lower levels than normal, most likely due to
nonsense-mediated decay (Figure S1B).
Because CypB is expressed in all cell types, and is highly
conserved from yeast to humans, we anticipated that homozygous
loss might cause developmental abnormalities during embryogen-
esis. Surprisingly, CypB knockout mice appeared normal at birth,
and both sexes were fertile. In addition, Ppib
2/2 mothers had no
apparent difficulties giving birth, feeding, or raising their pups. On
the other hand, homozygous CypB knockout mice had reduced
body size and weight, in comparison to littermate controls
(Figure 1C and 1D), and typically died between 40 and 50 weeks
of age of unclear etiology. A striking feature was pronounced
kyphosis, noted as early as 8 weeks after birth that progressed in
severity with age (Figure 1F, Figure 2A, Figure S2A). Dual-energy
x-ray absorptiometry further demonstrated this kyphosis, and
suggested that knockout mice had reduced bone density (data not
shown). Although rhizomelia has been described in some types of
osteogenesis imperfecta [4,5], we did not observe differences in the
ratio of femur to tibia lengths in CypB-deficient mice compared to
littermate controls (0.81960.027 vs. 0.82660.013) (Figure S2B).
Severe osteopenia and aberrant type I and type II
collagen in the absence of CypB
To study the pathophysiology of altered bone development,
Ppib
2/2 or littermate control mice were euthanized and femurs
dissected for analysis by microcomputed tomography. Serial
sections of femurs revealed dramatically reduced amounts of
trabecular bone in mice lacking CypB (Figure 2B). Average bone
volume was significantly reduced and the separation between
trabeculae was increased in mutant mice (Figure 2C).
Because of the critical role for collagen in directing bone
formation [21], we next analyzed collagen from Ppib
2/2 mice, as
was performed for CRTAP knockout mice [5]. Skin fibroblasts
were prepared from knockout and littermate control embryos and
maintained in culture. Collagen secreted into serum-free medium
was collected and fractionated on SDS-PAGE. Western blotting
revealed slightly delayed migration (Figure 3A), consistent with
increased post-translational modification, as was noted previously
in collagen from LEPRE1 or CRTAP mutant cells [3,4].
Samples of bone and cartilage were extracted by limited pepsin
digestion, and proteins resolved by SDS-PAGE. Coomassie blue
stained bands were excised, subjected to trypsinization, and
analyzed by tandem mass spectrometry. The tryptic peptide
containing proline-986 (975-DGLNGLPGPIGPPGPR-990) was
identified, and further analyzed by MS2 and MS3 for hydroxyl-
ation modifications (Figure 3B, Figure S3). Remarkably similar to
collagen from LEPRE1 mutant humans and CRTAP knockout
mice [5], multiple analyses demonstrated an almost complete
absence of 3-hydroxy proline in the peptide at Pro-986 from
CypB-knockouts, while collagen from wild type and heterozygote
littermates had abundant amounts of peptide containing hydroxy-
proline in this position. The known sites of prolyl–4 hydroxylation
at residues 981 and 987 were appropriately modified by
hydroxylation in the peptides from both wild type and knockout
collagen. Similar results were obtained for Type II collagen from
cartilage (Figure 3B).
3-hydroxylation of Pro-986 in type I collagen is required for
correct fibril formation because mutation of P3H1 or CRTAP
causes the accumulation of aberrant fibrils with wider than normal
diameter [4,5]. We therefore examined subcutaneous collagen
fibrils in CypB knockout mice by transmission electron microsco-
py. The majority of collagen fibrils in these mice were on average
1.45 times wider than similar samples from littermate control mice
(114.6 +/2 22.4 nm vs. 78.6 +/2 12.4 nm diameter) (Figure 3C).
Because of the reported interaction between CypB and type I
collagen precursors during their transit through the export
pathway [19], we next stained cells for endogenous collagen. In
the absence of ascorbic acid, the majority of collagen co-localized
with the ER-resident marker PDI (Figure 4). Upon addition of
ascorbic acid for 24 hours, collagen in wild type cells concentrated
in the area of the golgi apparatus, as indicated by co-staining with
a GM130 antibody [22]. However, in cells lacking CypB, a
significant amount of collagen remained in the ER (Figure 4).
Thus, CypB is important for appropriate subcellular localization of
collagen within the protein secretion system.
Author Summary
Osteogenesis Imperfecta (OI), also known as ‘‘brittle bone
disease,’’ is an inherited condition with multiple defects in
collagen-containing structures, including the bones, skin,
and other connective tissues. Patients with OI suffer from
short stature, scoliosis, thin skin, hearing loss, and, most
notably, fragile bones that break with little or no trauma.
Although many cases are due to dominantly inherited
point mutations in the collagen genes, autosomal
recessive forms have been described due to defects in
the genes for Prolyl-3-Hydroxylase-1 (LEPRE1) and Carti-
lage-Associated Protein (CRTAP), proteins that modify
newly synthesized procollagen. Some patients with OI do
not have mutations in any of the known disease-related
genes. Here, through the use of newly generated knockout
mice, we identify the endoplasmic-reticulum resident
prolyl-isomerase cyclophilin B (CypB) as a new autosomal
recessive OI gene in mice. CypB, P3H1, and CRTAP were
shown to have interrelated effects in maintaining their
respective protein levels and ability to bind to collagen.
These studies enhance our understanding about how
collagen, the most abundant protein in the body, becomes
properly assembled to form bones with adequate
strength.
Mutations in Ppib Result in OI
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Thin skin is a common feature of patients with OI. We noticed
that CypB 2/2 mice were easily identified by their loose skin
(Figure 5A). To determine whether this was related to a defect in
collagen, sections of skin were fixed and stained by H & E, or Sirrius
Red (Figure 5B and 5C). Cellular appearance was normal, however
wenoteddecreased intensityofSirriusredstaining,suggestinglower
concentrations of collagen in CypB-deficient skin. Total collagen
wasextractedfrom skin samples with pepsin digestion, and testedby
ELISA for type I collagen content, verifying this result (Figure 5D).
To quantitate the defect further, we performed tensile strength
testing of skin samples, as was done previously for Tenascin-X
deficient mice, which are a model for Ehlers2Danlos syndrome
[23]. Comparison of stress versus strain (Figure 5E) revealed several
abnormal properties of CypB2/2 skin samples, which were very
similar to published results from Tenascin-X knockout mice. The
‘toe’ region of the stress-strain curves, representing normal ranges of
skin stretching, were much longer than normal (Figure 5F). The
steep linear portion of the curves had flatter slopes (Figure 5G),
demonstrating dramatically lower stiffness of the aligned collagen
fibers,thought to be dueto the density and cross-linking of the fibrils
[23]. Lastly, much lower forces were required to break CypB-
knockout mouse skin (Figure 5H). All three parameters were
essentially the same between wild type and heterozygote mice.
Lastly, we prepared collagen from skin samples, and analyzed it
by mass spectroscopy. As described for bone and cartilage
Figure 1. Reduced body size in CypB–knockout mice. (A) The third exon of the Ppib gene, encoding CypB, was targeted by loxP sites knocked-
in to either side. Arrows indicate SacI sites used for Southern blot analysis of the targeted clones, probed from outside of vector sequences (grey
rectangle). Mice bearing this allele were mated to MMTV-Cre transgenic mice to delete the exon in the germ cells of female pups. Their offspring
demonstrated complete loss of CypB. (B) Southern blot of genomic DNA from targeted (‘T’) and wild-type (‘WT’) ES clones. (C) Western blot of CypB in
thymocytes from wild type (lanes 1, 4) or knockout (lanes 2, 3) mice. (D) Average weights of wild-type, heterozygous, or homozygous CypB–knockout
mice. n=3 WT littermates; n=10 Ppib+/2;n=1 2Ppib2/2 mice. Asterisks indicate points that were statistically significantly different by one-tailed
students T-test (p,0.05) from the heterozygote weights. (E, F) Typical appearance of wild type and knockout mice.
doi:10.1371/journal.pgen.1000750.g001
Mutations in Ppib Result in OI
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representing the 986-hydroxylated peptide (Figure S4).
CypB regulates P3H1
Several other investigators have reported that CypB is able to
bind to collagen, and to the P3H1 / CRTAP complex [5,8]. To
verify this in our system, we prepared recombinant CypB as a
GST-fusion protein from E.coli, and tested its ability to bind to
collagen in the form of gelatin linked to sepharose. GST-CypB
indeed bound stably to gelatin-sepharose, and there was no
interaction between the control protein GST and gelatin
(Figure 6A). Addition of cyclosporine A (CsA) completely blocked
Figure 2. Abnormal bone in CypB–knockout mice. (A) Total body radiographs of 38-week-old mice. Note the enhanced curvature of the spine
in the Ppib2/2 mouse. Bar=1 cm. (B) 3D reconstruction of slices from micro CT analysis of femurs from CypB knockout and littermate control mice.
(C) Bone volume/total volume, trabecular separation, and trabecular number in femurs analyzed by microCT at the indicated ages.
doi:10.1371/journal.pgen.1000750.g002
Mutations in Ppib Result in OI
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site of CypB (which binds to the twisted proline intermediate
during the cis-trans peptidyl prolyl isomerase reaction [24]) is
important for affinity to collagen.
We investigated whether recombinant CypB would also bind to
P3H1 from cells. Lysates from wild type fibroblasts were prepared,
incubated with the fusion protein, and then passed over
glutathione-agarose resin to recover GST-CypB. We observed a
moderate degree of retention of P3H1 specifically to GST-CypB,
and none to GST alone, indicating they may indeed interact.
(Figure 6B). However, we noted that Type I collagen also was
retained specifically in these pull-down experiments, raising the
alternative possibility that P3H1 might be indirectly associating
with CypB through collagen monomers acting as intermediate
bridges. To further explore this latter possibility, we repeated the
pull-down experiments in the presence of CsA, to inhibit CypB
binding to collagen. However, CsA had only a modest inhibitory
effect on the CypB-P3H1 association (Figure 6C), suggesting that
the proline-binding site of CypB is probably not involved in
interaction with P3H1. Interestingly, GST-CypB pulled down a
much larger fraction of cellular P3H1 when added to lysates from
Ppib2/2 cells, consistent with the idea that under normal
conditions, most P3H1 is already bound to endogenous CypB
(Figure 6C).
In conducting these studies, we also found that the amount of
P3H1 was relatively reduced in CypB-deficient cells (Figure 6D).
This effect was specific because there was not a similar reduction
in other ER-resident proteins, such as PDI, FKBP65, HSP47.
However, the residual P3H1 retained its ability to bind to collagen,
as determined by affinity to gelatin-sepharose (Figure 6E). Thus,
stable accumulation of P3H1 in fibroblasts depends upon CypB,
however it does not require CypB in order to associate with
collagen.
P3H1 regulates CypB
To investigate the reciprocal relationship of P3H1 effects on
CypB, several commercial shRNA lentivirus preparations were
tested, and two were found to cause significant depletion of P3H1
protein in murine fibroblasts. We found that in both cases,
reduction of P3H1 did not have any effect on intracellular levels of
CypB (Figure 7A). On the other hand, knockdown of P3H1
severely reduced the amount of CypB that could bind to gelatin-
sepharose in vitro, indicating that a substantial portion of CypB-
gelatin binding depends upon the P3H1 protein. This result was
obtained regardless of whether the cells were grown in the
presence or absence of ascorbic acid (Figure 7B), which is known
to increase collagen production and hydroxylation [25,26].
CRTAP regulates P3H1 and CypB
Like P3H1, CRTAP has been reported to be mutated in mice
and humans with OI. CRTAP does not have a known enzymatic
function, and, although collagen from CRTAP2/2 mice was
shown to have reduced prolyl–3-hydroxylation, its mechanism in
this process is not understood. Unfortunately, we were unable to
obtain antibodies that recognized the murine CRTAP, thus we
turned to a human cell system to explore its potential interactions.
HeLa cells were found to have easily detectable CRTAP. CypB
was knocked down using a shRNA lentivirus, and lysates were
tested as described above. Although CypB was efficiently reduced,
there was no impairment of either CRTAP accumulation, nor of
the binding of CRTAP to gelatin-sepharose (Figure 7C).
Knockdown of CRTAP in HeLa cells, on the other hand,
caused a substantial depletion of P3H1 (Figure 7D). In addition,
although there was not an effect of loss of CRTAP on CypB
intracellular levels, we did observe a dramatic impairment in the
ability of CypB from these lysates to bind to gelatin-sepharose
(Figure 7D). We conclude that CRTAP maintains the appropriate
Figure 3. Altered collagen in CypB–knockout mice. (A) Skin
fibroblasts from wild-type or CypB knockout mice were cultured in
serum free medium. Secreted collagen from the supernatant was
electropheresed on 5% SDS-PAGE and detected by Western Blotting.
Type I collagen from mutant animals demonstrated a subtle but
reproducible decrease in migration compared to wild type. (B) Mass-
spectroscopic analysis of type I and type II collagen from bone and
cartilage. Chromatogram of the parent ions in the mass spectra from
wild type and Ppib2/2 collagen tryptic-peptides. Wild-type collagen is
4-hydroxylated at pro-981 and pro-987, and 3-hydroxylated at pro-986.
Collagen from Ppib2/2 mice primarily lacked the pro-986 hydroxyl-
ation. Indicated peaks were analyzed by MS2 and MS3 to identify
hydroxylated proline residues (‘hP’). (C) Transmission electron micro-
graphs of subcutaneous tissue revealing abnormally thick collagen
fibrils in mutant mice in comparison to control mice. (bar=100 nm).
doi:10.1371/journal.pgen.1000750.g003
Mutations in Ppib Result in OI
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collagen.
Discussion
Collagen makes up the most abundant protein in the body,
and is critically important for structural elements of skin and
subcutaneous tissue, as well as for providing the osteoid framework
on which calcium phosphate precipitates during bone formation.
The problem of how microscopic cells synthesize and properly
build structures, such as bones, that are many orders of magnitude
larger than themselves is an important one in biology and
medicine, however the details of this complex process are
incompletely understood. It has been of great value to study
human and mouse mutants with abnormal bone development, like
OI, in order to identify the critical components of this system.
Eight types of OI have been described [2]. The initial
classification of types I – IV were based primarily on clinical
presentation, with type II (typically lethal in the perinatal period)
being the most severe. All four have subsequently been shown to
result from mutations in COL1A1 or COL1A2 genes. Types VII
and VIII are autosomal recessive, and are due to mutations in
CRTAP and LEPRE1 respectively, while the genetic basis of type
V and VI remains unknown. We provide here the first evidence
indicating an essential role for CypB in the biosynthesis of bone in
mice. Many of the features of OI were recapitulated in Ppib2/2
mice, including reduced body mass, kyphosis, and reduced bone
density. In addition to the poor quality and quantity of bone
mineralization, we found increased laxity and decreased strength
of the skin in these animals. Along with the abnormal appearance
of collagen fibrils by ultrastructural analysis of subcutaneous tissue,
this suggests that CypB provides an important function during the
generation of collagen in more tissues than just the skeletal system.
The occurrence of kyphosis in these mice may therefore be a
function of both decreased strength of connective tissue as well as
abnormal vertebral bones, since several genetic conditions with
primarily soft-tissue manifestations are associated with spinal
deformities [27–29]. Although this is the first report of deletion of
CypB and its role in bone formation, it is intriguing to note that
CypB has been linked previously to a skin disorder in horses
known as HERDA, in which affected animals develop hyperex-
tensible skin and scarring along the back [30]. HERDA is an
autosomal recessive disorder, and is due to a 39G.R point
mutation in CypB, however the molecular mechanism was not
previously described [31]. We suspect it may be related to the
mechanism we propose in this report, although why it selectively
affects the skin in horses is not clear. However, a distinguishing
feature of these two genetic conditions is the ultrastructural
appearance of collagen fibers, which are reduced in diameter in
HERDA-affected horses and larger than normal in CypB and
CRTAP mutant mice. This difference may be due to a residual
altered chaperone activity or glycosaminoglycan-binding property
of mutated CypB in HERDA [31], which is not present in the
knockout mice.
Cyclophilins form an ancient, highly conserved group of
proteins that are present in all eukaryotic cells, and in some
bacteria [32]. The role of CypB has been a mystery, although it
has been suggested to mediate prolactin receptor and Interferon
Regulatory Transcription factor 3 (IRF-3) signal transduction
[18,33,34]. Given the high degree of conservation of this gene, it
was surprising to us that Ppib2/2 mice were viable. However, we
did observe increased rates of death at approximately 1 year of
age. Our preliminary results seem to indicate that providing food
and water at a low level in the cages as mice age improves their
overall survival.
Our molecular studies provide a framework for understanding
the relatively complex interrelationships of the members of the
P3H1/CRTAP/CypB complex. Intracellular levels of P3H1 were
dependent upon both CypB and CRTAP individually. However,
P3H1 did not require either partner in order to maintain its ability
to bind stably to collagen in the form of gelatin-sepharose. Others
have previously shown that the prolyl-3-hydroxylation reaction of
P3H1 in the absence of partner proteins is intact [8]. However, we
did not observe appropriate prolyl–3-hydroxylation of residue
Figure 4. Abnormal localization of collagen in CypB–deficient cells. MEFs prepared from wild-type (WT) or CypB knockout mice (KO) were
cultured with or without 24hr stimulation with ascorbic acid (+AS). Cells were fixed, permeabilized, and co-stained for intracellular collagen and the
Golgi marker GM130 (A) or the ER-resident protein PDI (B). (bar=40 mm).
doi:10.1371/journal.pgen.1000750.g004
Mutations in Ppib Result in OI
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part, to reduced P3H1 levels in these mutant cells.
On the other hand, although intracellular levels of CypB did not
depend upon either CRTAP or P3H1, knockdown of either
significantly prevented the binding of CypB to gelatin-sepharose.
Although CypB has an endogenous collagen-binding property, we
observed that the extent of binding is relatively low. CypB in
complex with P3H1 was a much better substrate for affinity to
gelatin-sepharose. One conclusion from these studies is the
observation that in each condition that can cause OI (i.e. loss of
any member of the P3H1/CRTAP/CypB complex), there is a
significant loss of CypB binding to collagen (Figure 7). A possible
model, therefore (Figure 8), is that an important role for P3H1 is to
stabilize CypB on the newly synthesized procollagen molecule, in
Figure 5. Abnormal skin in CypB–deficient mice. (A) Typical appearance of wild-type (left) and Ppib2/2 (right) mice demonstrating the laxity of
skin. (B) Sections of skin were fixed and stained with H&E, revealing normal cellular architecture of the dermis. Bar=200 mm. (C) Sirrius red staining
demonstrates reduced collagen in skin sections from CypB-knockout mice. Bar=250 mm. (D) Quantitation of total type I collagen from skin
determined by ELISA. (E) Representative stress vs. strain (SvS) curves of skin from wild type, heterozygote, or CypB knockout mice. (F) Toe lengths of
SvS curves indicating the normal range of skin stretchiness. (G) Slopes of SvS curves prior to fracture indicate that CypB2/2 collagen fibers are more
easily pulled past each other. (H) Force of breakage was much lower in CypB-deficient skin (For all comparison, n=4; *P,0.05; **P,0.01).
doi:10.1371/journal.pgen.1000750.g005
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20% of the residues in type I collagens, so it would not be
surprising if these proteins needed special help during folding.
CRTAP, according to this model, would provide support by
maintaining P3H1 levels. Consistent with this model is the recent
finding that the cis-trans peptidyl prolyl isomerase activity of CypB
is available and active in the complex with P3H1 and CRTAP [7].
This is in agreement with our finding that CypB/P3H1 binding is
not ablated by addition of CsA.
Alternative mechanisms for CypB are possible, however. Others
have shown that abnormally folded collagen is degraded by
proteasomes, which reside in the cytosol, thus would require
retrotranslocation [35]. Cyclophilin B has been implicated in
retrotranslocation [18], thus its absence in knockout mice likely
compounds the problem in cells with high collagen synthetic rates.
Our finding of abnormally localized collagen in the ER of CypB
deficient cells is consistent with a delay in their processing or
removal to the cytosol for proteasomal degradation.
Figure 6. Decreased levels of P3H1 protein in the absence of CypB. (A) GST-cyclophilin B or GST was mixed and pulled down with gelatin
sepharose in the absence or presence of cyclosporine A. Proteins were visualized by blotting with antibody to GST. (B) Lysates from wild type cells
were mixed with recombinant GST-cyclophilin B or GST, and bound proteins isolated using GSH-agarose prior to SDS PAGE. Proteins were visualized
by western blotting with antibodies to the indicated proteins. (C) Binding of GST-CypB to P3H1 in lysates from wild-type (WT) or CypB-knockout
fibroblasts (KO) was detected by chromatography on glutathione-agarose followed by western blotting for P3H1. Although P3H1 is present at much
lower levels in the absence of CypB, a greater fraction of it binds to recombinant CypB in vitro. (D) Western blot of the indicated proteins from lysates
of wild-type and CypB knockout skin fibroblasts. Blotting for beta-actin was performed as a loading control. (E) Proteins from lysates of wild-type and
CypB–knockout skin fibroblasts were isolated on gelatin-sepharose. Bound proteins were eluted and detected by western blotting with antibodies to
the indicated proteins.
doi:10.1371/journal.pgen.1000750.g006
Mutations in Ppib Result in OI
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identified disease mutations. Our results suggested to us the
possibility that CypB might be a potential underlying cause in a
subset of these people. Indeed, while this manuscript was in
revision, several humans with recessive OI of the severe neonatal
type were reported to have mutations in the PPIB gene [36,37].
The clinical features of the human cases were very similar to
findings presented here, although they had increased numbers of
bone fractures, possibly due to the relatively greater stress of birth
in humans compared to mice. In addition, diseases of other types
of collagen, such as Ehlers-Danlos syndrome [38], may also result
from alterations in CypB.
Cyclosporin A is a commonly used immunosuppressant. It
works by binding to cyclophilin A, which then blocks the
interaction of calcineurin with its downstream target NFAT
[12,39]. It is known, however, that cyclosporine also binds
cyclophilin B, and causes it to be released from the cell [40].
Cyclosporin A has multiple toxic side effects in humans, including
reduction in bone mineral density [41]. Although the effects of
cyclosporin A are complex, this toxicity may in part be mediated
through inhibition of CypB, as suggested by this new work. Our
findings also raise the possibility that this could turn out to be a
side effect of non-immunosuppressive cyclophilin binding drugs,
which are currently being tested clinically for anti-viral properties
[42] and proposed as a new treatment for muscular dystrophy in
order to inhibit cyclophilin D [43].
Materials and Methods
Mice
All animal procedures were reviewed and approved by the
Institutional Animal Care and Use Committee. A targeting
plasmid was generated using a BAC clone containing the entire
Ppib gene from 129SvJ genomic DNA. Germline transmission in
129 x C56B6 mice was achieved essentially as previously described
[44]. The initial mice carried a conditional knockout allele
(Figure 1) in case total deletion would be embryonic lethal. Mice
were crossed to MMTV-Cre transgenic mice to cause deletion of
the floxed exon 3 in female germ cells, after which the Cre
transgene was bred out of the offspring, since it was no longer
needed. Pups from these females were heterozygous for the KO
allele, and were bred as needed to generate heterozygote or
homozygote mutant, or littermate control wild type mice.
Cell culture and lentiviral knockdown
Mouse embryonic fibroblasts (MEFs) or skin fibroblasts were
generated as previously described [45]. Cells were maintained in
DMEM +10% fetal calf serum with 50 mg/ml ascorbate (sigma)
unless otherwise indicated. For isolation of secreted collagen, cells
were cultured in serum free DMEM containing ascorbate. For
knockdown in skin fibroblasts, Lentiviral vectors encoding small
hairpin interfering RNA sequences (shRNA) were obtained from
sigma (LEPRE1 and CypB) or Open Biosystems (CRTAP).
Figure 7. P3H1 and CRTAP are required for efficient binding of CypB to collagen in vitro. (A) Mouse fibroblasts were transduced with two
different shRNA lentiviruses (#65 and #67) to knockdown P3H1 or a control lentivirus (‘‘C’’). Lysates were mixed with gelatin-sepharose to adsorb
collagen binding proteins, and then recovered for western blotting, as indicated. Total cellular levels of CypB were not affected by knockdown of
P3H1, however binding to gelatin was reduced. (B) As described in (A) in the absence or presence (‘‘AS’’) of ascorbic acid in the medium. (C) HeLa cells
were transduced with a CypB specific shRNA lentivirus or control and lysates probed for gelatin-binding proteins as described. Knockdown of CypB
did not affect CRTAP levels or binding to gelatin. (D) Knockdown of CRTAP in HeLa cells reduced P3H1 cellular levels and blocked the binding of CypB
to gelatin in vitro.
doi:10.1371/journal.pgen.1000750.g007
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plasmids (Invitrogen) for generating lentiviral particles. Skin
fibroblasts were transduced with specific lentiviruses and selected
by 2 ug/ml puromycin (Invitrogen).
Radiographs and cancellous bone analysis
Mice were euthanized and analyzed by radiography (GE AMX 4)
of whole body or hind limbs. The femur was cleaned of soft tissue and
measured ex-vivo on a uCT 35 micro-CT scanner (Scanco Medical,
Basserdorf,Switzerland). Trabecular architecture was measured
distally from the growth plate (70 kVP, increment 7 um) at a
resolution of 7 um. The analysis region was represented by100 slices.
Collagen analysis
To analyze modification of secreted procollagen, confluent
fibroblasts were stimulated in serum-free conditions containing
ascorbate during the 48 hrs. The harvested media were electro-
phoresed on 5% SDS polyacrylamide gels under reducing
conditions and processed for westernblotting with type I collagen
antibody (SouthernBioTech). To examine the overall architecture
and quantify the collagen content in a given area of mouse skin
tissue, sections of paraffin-embedded skin sample from abdomen
were stained with H&E or Picrosirius red (Polysciences, Inc.). Type
I collagen in the extract from skin samples was quantified with
Mouse Type I Collagen Detection Kit (Chondrex, Inc.)
Protein identification via in-gel trypsin digest and
nanoLC-MS/MS with hybrid orbitrap/linear ion trap mass
spectrometry
To determine prolyl 3-hydroxylation in collagen samples from skin,
bone and cartilage, collagen was solubilized and extracted by a limited
d i g e s t i o nw i t hp e p s i n( 1 0 0mg/ml; Calbiochem) in 0.5N acetic acid for
48 hr. This extracts were resolved by SDS-PAGE. For collagen
samples obtained from skin fibroblast culture, the harvested culture
media were concentrated by Centricon (Millipore) and resolved by
S D S - P A G E .T h eC o o m a s s i eB l u es tained SDS-PAGE gel bands were
prepared for mass spectrometry analysis using the following
procedures. The gel bands were destained with 50 mM Tris, pH
8.1/50% acetonitrile until nearly clear. The bands were then reduced
with 30 mM DTT/50 mM Tris, pH 8.1 at 55uC for 40 minutes and
alkylated with 40 mM iodoacetamide at room temperature for 40
minutes in the dark. Proteins were digested in-situ with 30 ul
(0.004 ug/ul) trypsin (Promega Corporation, Madison WI) in 20 mM
TrispH 8.1/.0002% Zwittergent 3–16,at 37uCov ern ightfoll owedb y
peptide extraction with 60 ul of 2% trifluoroacetic acid, then 60 ul of
acetonitrile. The pooled extracts were concentrated to less than 5 ul
on a SpeedVac spinning concentrator (Savant Intruments, Holbrook
NY) and then brought up in 0.15% formic acid/0.05% trifluoroacetic
acid for protein identification by nano-flow liquid chromatography
electrospray tandem mass spectrometry (nanoLC-ESI-MS/MS) using
a ThermoFinnigan LTQ Orbitrap Hybrid Mass Spectrometer
Figure 8. A working model to summarize the interaction data posits that CRTAP and CypB both serve to stabilize the accumulation
of P3H1 within cells. P3H1 not only hydroxylates the 3 position of proline 986, but also plays a key role by facilitating the binding of CypB to
collagen within the ER. In all 3 conditions that lead to OI, P3H1 hydroxylation is absent, and CypB binding to collagen is reduced or absent.
doi:10.1371/journal.pgen.1000750.g008
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nanoLC-2D HPLC system (Eksigent, Dublin, CA). The digest
peptide mixture was loaded onto a 250nl OPTI-PAK trap
(Optimize Technologies, Oregon City, OR) custom packed with
Michrom Magic C8 solid phase (Michrom Bioresources, Auburn,
CA). Chromatography was performed using 0.2% formic acid in
both the A solvent (98%water/2%acetonitrile) and B solvent (80%
acetonitrile/10% isopropanol/10% water), and a 5%B to 45%B
gradientover60minutesat 400 nl/minthrougha Michrom packed
tip capillary Magic C18 75 mm x 200 mm column. The initial LTQ
Orbitrap massspectrometerexperimentwassettoperform a FTfull
scan from 375–1600 m/z with resolution set at 60,000 (at 400 m/z),
followed by linear ion trap MS/MS scans on the top five ions.
Dynamic exclusion was set to 2 and selected ions were placed on
an exclusion list for 40 seconds. The lock-mass option was enabled
for the FT full scans using the ambient air polydimethylcyclosilox-
ane (PCM) ion of m/z=445.120024 or a common phthalate ion
m/z=391.284286 for real time internal calibration.
The experiment to target the hydroxyproline sites of the peptide
DGLNGLPGPIGPPGPR, relied on performing MS3 on the
abundant y-ion from fragmentation N-terminal to a proline
residue. The Orbitrap full scan used a list of masses for the
[M+2H]2+ ions of this peptide without and with 1 to 5
hydroxyprolines to trigger the data dependant ion trap MS/MS
scans. The ion trap MS/MS/MS scans were triggered on the most
abundant ion of the MS/MS scan. If no masses from the list were
detected in the Orbitrap full scan, then the most abundant ions
triggered the MS/MS events.
The MS/MS raw data were converted to DTA files using
extract_msn.exe from Bioworks 3.2 and correlated to theoretical
fragmentation patterns of tryptic peptide sequences from the
Swissprot databases using Mascot
TM 2 (Matrix Sciences London,
UK). All searches were conducted with fixed modification of
carbamidomethyl-cysteine and variable modifications allowing
oxidation of methionines for methione sulphoxide, oxidation of
prolines for hydroxyproline, and protein N-terminal acetylation.
The search was restricted to full trypsin generated peptides
allowing for 2 missed cleavages and was left open to all species.
Peptide mass search tolerances were set to 10 ppm and fragment
mass tolerances are set to60.8 Daltons. All protein identifications
were considered when Mascot individual peptide scores were
above the 95% percentile for probability and rank number one of
all the hits for the respective MS/MS spectra. The MS/MS/MS
scans were analyzed manually.
Transmission electron microscopy
Skin tissues taken from lower abdomen were processed for
transmission electron microscopy as described [46]. Skin biopsy
was fixed overnight in 0.1% glutaraldehyde and 4% formalde-
hyde in 0.1-M phosphate buffer at pH 7.2. After primary
fixation, tissues were rinsed in 0.1-M phosphate buffer, followed
by postfixation in phosphate-buffered 1% osmium tetroxide.
After rinsing in three changes of distilled water, the tissue was
stained en bloc with 2% uranyl acetate at 55uC. The tissues were
rinsed in distilled water, dehydrated in progressive concentrations
of ethanol and propylene oxide, and embedded in Spurr resin.
The resin was polymerized at 65uC. Thin sections were mounted
on copper grids for evaluation with a transmission electron
microscope (JEOL JEM-1400; JEOL USA, Peabody, Massachu-
setts). To analyze fibril morphology and density, we selected 5
adjacent regions lying just beneath the epidermal basement
membrane from each of 4 sex- and age- matched wild type and
CypB knockout littermates.
Immunofluorescence
MEFs were cultured on coverslides, fixed with 2.5% paraformal-
dehyde in PBS and permeabilized using 0.2% Triton X-100 in PBS
for 2 min. Cells were blocked with PBS containing 5% goat serum
and stained for intracellular collagen with anti-mouse collagen
antibody (AB765P; Chemicon). Cellular localization was verified by
costaining with anti-PDI (stressgen) or anti-GM130 antibody (BD).
Samples were visualized using a Zeiss epifluorescence microscope.
Cell lysis, immunoblotting, and affinity chromatography
with gelatin-sepharose
Cells were lysed in 1% NP-40, 20 mM HEPES [pH 7.4], 5 mM
NaCl, 5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM PMSF,
10 mg/ml leupeptin, and 45 mg/ml aprotinin. 50 mg of protein
lysates were resolved by 8% SDS-PAGE and transferred to charged
nylon membranes (Millipore). Western blots were probed for
cyclophilin B with rabbit polyclonal antibody (Affinity BioReagents)
or mouse monoclonal antibody (k2E2; Abcam), type I collagen
(SouthernBioTech), P3H1 (Abnova), PDI (Stressgen), Hsp47
(Stressgen), FKBP65 (BD), GST (Sigma), CRTAP (Abnova) and
beta-actin (Sigma). Reactive bands were visualized with a secondary
antibody conjugated with HRP (Zymed) and chemiluminescence
(Thermo scientific). For pulldowns, cell extracts were mixed with
GST-cyclophilin B or GST and treated with GSH-agarose (GE
healthcare), washed in lysis buffer and eluted by SDS sample buffer.
For binding assays with gelatin-sepharose (GE healthcare), lysates
containing approximately 1 mg of total protein were mixed with
gelatin-sepharose for 3 h at 4uC with continuous rotation. The
resulting precipitate was washed twice with lysis buffer, subjected to
SDS-PAGE, and then blotted for the indicated protein.
Quantitative RT–PCR
Total RNA was purified with TRIZOL (Invitrogen) from
splenocytes or MEFs and used as a template for synthesis of cDNA
with SuperScript III First Strand RT-PCR kit (Invitrogen). With
TaqMAN Gene Expression Assays (Applied Biosystems), Ppib and
Actin mRNA levels were measured on a ABI 7900HT Thermo-
cycler (Applied Biosystems). All q-PCR reactions were run in
quadriplicate. Ppib level were normalized to constitutively expressed
actin. The graph of fold change was generated by DDCt values.
Biomechanical testing
Skin from 38-weeks old female mice was biomechanically tested
for tensile strength as described [23]. Stress was calculated by
normalizing measured force with cross-sectional area. The strain
at a stress equivalent to 0.05 (Newtons/mm) was used as the toe
length. Slope was calculated with data in the linear portion (above
0.2 Newtons/mm). Highest force was normalized with cross-
sectional area for failure force.
Supporting Information
Figure S1 (A) Western blot of lysates from splenocytes (left) and
MEFs (right) using two different antibodies to verify absence of
immunoreactive CypB in knockout cells. (B) Real time rtPCR of
CypB mRNA normalized to actin message levels in splenocytes
from wildtype or knockout animals.
Found at: doi:10.1371/journal.pgen.1000750.s001 (1.19 MB TIF)
Figure S2 Radiographs. (A) Total body radiographs showing the
skeletons of mice at 24 and 63 weeks of age. Bar=1 cm. (B)
Radiographs of lower limbs. The measured ratios of femur to tibia
were similar in all mice, regardless of CypB.
Found at: doi:10.1371/journal.pgen.1000750.s002 (1.86 MB TIF)
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demonstrating the data used for identification of hydroxylated
proline residues.
Found at: doi:10.1371/journal.pgen.1000750.s003 (1.95 MB TIF)
Figure S4 Ion-current LC profile of the type I collagen tryptic
peptides containing residue pro-986 from skin of wild type and
knockout mice.
Found at: doi:10.1371/journal.pgen.1000750.s004 (0.62 MB TIF)
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